Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. - Wikidata - awgldk - TriplyDB

Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification.

Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification.

http://www.wikidata.org/entity/Q53153874

about

Host-microbiome interaction in Crohn's disease: A familiar or familial issue?Role of genetics in pediatric inflammatory bowel disease Murine models of inflammatory bowel disease (IBD): challenges of modeling human disease The diagnostic approach to monogenic very early onset inflammatory bowel disease Current issues of pediatric inflammatory bowel disease in Korea.Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics.NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2 Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4 Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease.Characteristics of Pediatric Inflammatory Bowel Disease in Korea: Comparison with EUROKIDS Data.Impact of pediatric inflammatory bowel disease on linear growth: Data from a national cohort study in Saudi Arabia The incidence of Crohn's disease and ulcerative colitis since 1995 in Danish children and adolescents <17 years - based on nationwide registry data.Geographic mapping of Crohn's disease and its relation to affluence in jiangsu province, an eastern coastal province of china.Relationship between proximal Crohn's disease location and disease behavior and surgery: a cross-sectional study of the IBD Genetics Consortium Imaging of the small bowel: Crohn's disease in paediatric patients.The role of the innate and adaptive immune system in pediatric inflammatory bowel disease.Predictors of depression in youth with Crohn disease.Randomized efficacy trial of two psychotherapies for depression in youth with inflammatory bowel disease.Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: a pilot study.Inflammatory bowel disease in pediatric and adolescent patients: a biomolecular and histopathological review Rectal microRNAs are perturbed in pediatric inflammatory bowel disease of the colon.Alterations in the gut microbiome of children with severe ulcerative colitis Utility of neutrophil Fcγ receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn's disease.IL23R and ATG16L1 variants in Moroccan patients with inflammatory bowel disease Nutritional status and growth in Korean children with Crohn's disease: a single-center study Serum anti-glycan antibodies in paediatric-onset Crohn's disease: association with disease phenotype and diagnostic accuracy.Investigation of the enteric pathogenic potential of oral Campylobacter concisus strains isolated from patients with inflammatory bowel disease.The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease: a systematic review and meta-analysis.Gender differences in paediatric patients of the swiss inflammatory bowel disease cohort study Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example A retrospective study showing maintenance treatment options for paediatric CD in the first year following diagnosis after induction of remission with EEN: supplemental enteral nutrition is better than nothing!The microaerophilic microbiota of de-novo paediatric inflammatory bowel disease: the BISCUIT study.Immunophenotype in orofacial granulomatosis with and without Crohn's disease.Pediatric inflammatory bowel disease in Greece: 30-years experience of a single center.Feasibility and validity of the pediatric ulcerative colitis activity index in routine clinical practice Inflammatory bowel disease-the role of cross-sectional imaging techniques in the investigation of the small bowel Focally enhanced gastritis in newly diagnosed pediatric inflammatory bowel disease Evidence for non-neutralizing autoantibodies against IL-10 signalling components in patients with inflammatory bowel disease Inflammatory bowel disease in pediatric patients: Characteristics of newly diagnosed patients from the CEDATA-GPGE Registry.Surgical strategies in paediatric inflammatory bowel disease.

P2860

Q26776158-37F71566-0CAE-4F1A-973C-8B424FCE3D57 Q26825628-A51EC5ED-2F70-4015-A23A-A45B61E4FF92 Q26863622-07154787-D2BF-4401-B6B8-10D2DC60B393 Q27015077-2FEBFFF3-8084-4C68-83AB-D9E8E1A17D40 Q27687199-DD6D2B3E-AEFD-46F7-83B8-470DE92E608D Q27691430-E25A9778-4E2E-418A-BA7A-5A1BC3E8800D Q28247419-35AEC47D-C864-417D-A7BE-B6FAB48A3913 Q28250884-6D3265C6-B971-41DF-8A9D-C64AF8F5CF64 Q30490594-9BF3B57B-438F-4768-8957-6CDE79AEDCBB Q30949486-5E252B97-F9D0-4324-B249-051D128B8E72 Q31061123-0B8E4355-849F-4AE6-90A6-FB504DED050C Q31094304-7B103777-2427-4699-8F58-062F4A318AD2 Q33563024-7720D002-DD31-4495-937C-7E5F2EA18FC4 Q33763119-A8E8933D-49DD-4674-BFAD-6E56F70075AD Q33812863-574B56AC-8DBB-4052-9A72-851D5354F414 Q33830707-A974BB0B-6546-4714-AC56-58C7F12A4BA3 Q33896826-5B6B10EB-1169-44BA-9E4C-B6D4690DA32B Q33922847-3AA6F68C-F9F7-497F-814C-DAC86D6B8FA6 Q34021834-286150AE-2C04-4A2D-A81B-44B19FDCA239 Q34036608-63EFFC78-490B-4EF7-9E73-AEB6902A683C Q34097859-D1C2936B-5DA1-4427-8FC1-E2AE7603D3AF Q34101549-6A09ADF6-FD39-4516-A4AF-15AD32E87DE8 Q34117832-9571DC99-A3AA-4828-8873-5B5B701ECB76 Q34174340-94CDEA00-E86F-4F4B-939E-961931CEF8A1 Q34182085-8D5B9E48-7A09-4D8F-89C6-19B6B928C14E Q34258150-46005958-72E7-46B5-A73A-C87FB9BBE9E5 Q34279038-ADA611D2-1955-4575-995D-A554F1AFA00B Q34344472-F2D49D20-9D67-44C6-B5D1-7EAA0AF9428E Q34403836-6E5CCD78-1258-4632-819A-951E28D6CDED Q34464210-AE9101EA-5421-45C0-A02D-76038800AA0F Q34523498-C8140FA2-ED88-4163-A470-EAFCD44A118A Q34648376-45D37E84-7FFB-47DD-8853-2A8D528D2CD2 Q34654139-3CD8FB36-AAD2-4EEC-BB7F-5EE67D9CCB34 Q34907483-7A7B95B3-FDCF-4BCD-AA00-94699D02BC05 Q35020069-3F26988B-8B52-486F-B3E6-D896E41B485E Q35088619-10FD5203-792E-472D-A6DE-7ECF7693BD16 Q35097250-34AD6FCD-E7FD-493B-A70B-427D6F645842 Q35104872-DAA55B7E-0F5E-4096-A664-B5A52A44D889 Q35182768-028D0850-DF5B-4783-8E4E-8D6190C019B4 Q35651441-DFB69A39-1038-4044-BD95-F7244B3C211E

P2860

Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification.

http://www.wikidata.org/entity/Q53153874

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Pediatric modification of the ...... ase: the Paris classification.

@en

Pediatric modification of the ...... ase: the Paris classification.

@nl

type

label

Pediatric modification of the ...... ase: the Paris classification.

@en

Pediatric modification of the ...... ase: the Paris classification.

@nl

prefLabel

Pediatric modification of the ...... ase: the Paris classification.

@en

Pediatric modification of the ...... ase: the Paris classification.

@nl

P1433

Q53153874-F7DF8F70-AE41-46DA-9BD6-6DBC05E3BF98

P1476

Q53153874-B38D5E05-0C8D-443B-B049-34A6153D1F3C

P2093

Q53153874-14A530FC-1724-4D4C-A157-E9074AC18BE3

Q53153874-2AFD05A1-FF27-46C6-A114-09EEC1F4DCAB

Q53153874-37872157-B650-4058-B566-0CDF8EFC2018

Q53153874-4D575ED3-ADFF-4EB4-82F3-5265F57BB9AD

Q53153874-6431BAA2-3608-4702-9F44-C0818C227E81

Q53153874-6E43940B-7CA1-4118-9F47-6F5E8886AF1C

Q53153874-80D65D9A-4EB2-4F2C-97ED-DE0BE2054F8D

Q53153874-837FFA18-4A56-4362-B382-F99200C631A7

Q53153874-B4F8E4D4-89C4-4D76-869F-DFE7BCF5B576

Q53153874-B8FEC8D9-3D14-4AC2-8656-D7834F1EBF9B

P304

Q53153874-0A680D80-BB3E-4EF9-886F-C64F07EAC803

P31

Q53153874-454130E6-708A-4713-BC6B-E657276E6615

P356

Q53153874-EADE1B4F-28CF-456A-8047-95BA52FA736F

P433

Q53153874-AB98E74A-1F04-4638-85E4-CD7FA66C73B7

P478

Q53153874-402A7469-8E39-4310-B9F6-39F1E74E0230

P577

Q53153874-20C77DA2-CD07-43AE-A776-0EC193803EA8

P5875

Q53153874-3D7F7515-7794-4443-A0E4-9480F7ECE685

P698

Q53153874-EE2EB065-C987-4090-8BCA-03926FEE76D5

P921

Q53153874-20DAA56C-9695-43A2-B703-869522B87E9C

Q53153874-FA75B6D4-4964-4A46-A898-B8CFDEAD9F49

P356

P1433

Inflammatory Bowel Diseases

P1476

Pediatric modification of the ...... ase: the Paris classification.

@en

P2093

Anne Griffiths

http://www.w3.org/2001/XMLSchema#string

Arie Levine

http://www.w3.org/2001/XMLSchema#string

Dan Turner

http://www.w3.org/2001/XMLSchema#string

David C Wilson

http://www.w3.org/2001/XMLSchema#string

Frank M Ruemmele

http://www.w3.org/2001/XMLSchema#string

James Markowitz

http://www.w3.org/2001/XMLSchema#string

Jeffrey S Hyams

http://www.w3.org/2001/XMLSchema#string

John Fell

http://www.w3.org/2001/XMLSchema#string

Marla Dubinsky

http://www.w3.org/2001/XMLSchema#string

Mary Sherlock

http://www.w3.org/2001/XMLSchema#string

P304

1314-1321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IBD.21493

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51115235

http://www.w3.org/2001/XMLSchema#string

P698

21560194

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases